サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1624189

オルガノイドの市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：タイプ別、用途別、供給源別、提供別、方法別、地域別

Organoids Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, Source, Offering, Method, and Geography

出版日
ページ情報
英文 297 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
オルガノイドの市場規模・予測、世界・地域シェア、動向、成長機会分析レポート：タイプ別、用途別、供給源別、提供別、方法別、地域別
出版日: 2024年11月26日
発行: The Insight Partners
ページ情報: 英文 297 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

弊社の新しい調査レポート「オルガノイド市場の2031年までの予測：世界分析：タイプ、用途、供給源、地域別」によると、オルガノイド市場は2023年の30億3,000万米ドルから成長し、2031年には150億1,000万米ドルに達すると予測され、2023年から2031年にかけて22.1％のCAGRを記録すると予測されています。オルガノイド市場の成長要因としては、新規薬剤スクリーニングサービスに対する需要の高まりや、オーダーメイド薬剤の人気の高まりなどが挙げられます。しかし、熟練した専門家の不足や厳しい安全規制が市場成長の妨げとなっています。

オルガノイドは、単純な組織工学的細胞ベースのin vitroモデルであり、対応するin vivo組織の複雑な構造と機能の多くの側面を再現します。また、診断、疾患モデル、創薬、個別化医療にも利用できます。

北米がオルガノイド市場を独占しています。米国の市場企業は、足場を固めるために有機的成長戦略に注力しています。2023年2月、Molecular Devices, LLC.とHUB Organoids（HUB）は、前臨床から臨床への薬剤減少を段階的に減少させる次世代3D生物学技術の開発を継続する戦略的提携を発表しました。さらに、研究開発活動の増加、組織工学と臓器移植の需要の高まり、オルガノイドの高い導入率が、国内のオルガノイドサービス市場を牽引しています。オルガノイドは、生物医学研究に関連するこれまでのいくつかの制限を克服する可能性を持っており、ヒトの研究開発におけるメカニズム的洞察を研究者が利用できるようにすること、ヒト疾患の正確なモデルを作成すること、再生医療用の患者に適合した組織ソースを生成することに高い関心が寄せられています。アジア太平洋地域は、2023年から2031年にかけて最も高いCAGRを記録すると予測されています。

新興国での主な発展が今後の市場開拓の機会をもたらす

ヘルスケアの進展により、オルガノイドの需要は世界中で増加しています。この需要増加は、世界レベルでの新製品開発、買収、提携、製品発売、承認に寄与しています。主要市場企業は、効率的なサービスと製品の革新と開発を確実にするための活動に関与しています。最近の動向のいくつかを以下に示す：

2024年6月、Molecular Devices, LLC.は英国のカーディフに専用施設を正式に開設しました。数百万ポンドを投じたこの施設は、同社独自のバイオプロセスワークフローと革新的なバイオリアクター技術に対応するよう設計され、PDOの大規模かつ品質管理された生産を可能にしました。3D対応の再現性の高いPDOをカスタムサービスとして大量に提供し、分析に適した形で凍結保存することができます。研究者は必要に応じてこれらの製品を解凍、プレート化し、使用することができます。

2024年5月、バイオテクノロジー企業のInSphero社は、フランクフルトのGenome Biologics社とパートナーシップ契約を締結しました。このパートナーシップにより、InSphero社はGenome Biologics社の3D心臓オルガノイド・プラットフォームを商品化する独占的世界権を獲得します。このプラットフォームは、新しい治療法を生み出すための正確でスケーラブルな疾患特異的オルガノイドモデルを提供し、心臓病研究の最前線に位置します。

2023年7月、モレキュラーデバイスは、ハイスループットアプリケーションのための独自のバイオプロセス技術を用いたカスタム・オルガノイドライン拡張サービスを開始しました。

2023年2月、Molecular Devices, LLC.とHUB Organoids（HUB）は戦略的提携を発表し、前臨床から臨床への薬剤減少を段階的に減少させる次世代3D生物学技術の継続的開発に貢献します。

2022年12月、Molecular Devices, LLC.はCellesce Ltd.を買収しました。この買収は、受託開発・生産サービスを通じて、薬剤スクリーニングを含む様々な目的のための大規模PDOの生産に焦点を当てています。

2021年8月、STEMCELL TechnologiesとHubrecht Organoid Technology（HUB）は契約を締結しました。この契約の一環として、STEMCELLのコントラクトアッセイサービス部門は、肺、腸、肝臓オルガノイドなどの組織由来オルガノイドを、前臨床毒性学スクリーニングや非がん薬開発サービスのためにHUBに提供し始めました。これらのサービスは、研究者や医薬品開発組織による前臨床試験プログラムへのオルガノイドの統合を促進し、新治療法の迅速かつ経済的な上市を支援するものです。

このような新興国市場の主な発展、市場投入、市場関係者間の戦略的提携は、オルガノイド市場開発に十分な機会を創出します。

用途別洞察

用途別では、発生生物学、感染症病理学、再生医療、薬剤毒性・有効性試験、創薬・個別化医療、その他に区分されます。発生生物学疾患分野は2023年に市場で最大のシェアを占め、さらに2023年から2031年にかけて最も高いCAGRを記録すると予測されています。

供給源に基づく洞察

オルガノイド市場は、供給源に基づいて多能性幹細胞と臓器特異的成体幹細胞に分けられます。2023年の市場では、多能性幹細胞分野が大きなシェアを占めています。多能性幹細胞セグメントは予測期間中に高いCAGRを記録すると予測されています。

オルガノイド市場競合情勢と主な発展

STEMCELL Technologies Inc、Molecular Devices, LLC、InSphero、Definigen、Organoid Therapeutics、Thermo Fisher Scientific Inc、Corning Inc、Merck KGaA、HUB Organoids B.V.（Hubrecht Organoid Technology）などは、オルガノイド市場で事業を展開する主要企業です。

米国食品医薬品局（FDA）、疾病対策予防センター（CDC）、世界疾病負担調査（Global Burden of Disease Study）などは、オルガノイド市場レポート作成時に参照した一次情報および二次情報です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 重要な洞察

第3章 調査手法

  • 2次調査
  • 1次調査
    • 仮説の策定
    • マクロ経済要因分析
    • 基礎数値の開発
    • データの三角測量
    • 国レベルのデータ

第4章 オルガノイド市場情勢

  • PEST分析

第5章 有機合成医薬品市場力学

  • オルガノイド市場- 主要市場力学
  • 市場促進要因
    • 腫瘍モデリングとバイオバンクの需要増加
    • 個別化医薬品の採用急増
  • 市場抑制要因
    • 熟練専門家の不足
  • 市場機会
    • 創薬活動の焦点
  • 今後の動向
    • オルガノイドとOrgan-on-a-Chipの組み合わせ
  • 促進要因と抑制要因の影響

第6章 オルガノイド市場-世界市場分析

  • オルガノイド市場の収益、2021-2031年
  • オルガノイド市場の予測分析

第7章 オルガノイド市場分析-タイプ別

  • 腸
  • 肝臓
  • 胃
  • 膵臓
  • 肺
  • 脳
  • 腎臓
  • その他

第8章 オルガノイド市場分析-用途別

  • 発生生物学疾患
  • 感染症病理学
  • 再生医療
  • 薬物毒性および有効性試験
  • 創薬と個別化医療
  • その他

第9章 オルガノイド市場分析：供給源別

  • 多能性幹細胞
  • 臓器特異的成体幹細胞 70

第10章 オルガノイド市場分析-提供別

  • 器具
  • 消耗品
  • サービス

第11章 オルガノイド市場分析- 方法別

  • マイクロパターンプレート
  • 超低アタッチメントプレート
  • ハンギングドロップ
  • 微小液滴またはエマルジョン
  • その他

第12章 オルガノイド市場分析- 地域別

  • 概要
  • 北米
    • 北米
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 欧州
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋
      • 日本
      • 中国
      • インド
      • 韓国
      • オーストラリア
      • シンガポール
      • タイ
      • マレーシア
      • ベトナム
      • インドネシア
      • フィリピン
      • アジア太平洋地域のその他諸国
  • 中東・アフリカ
    • 中東・アフリカ
      • サウジアラビア
      • 南アフリカ
      • アラブ首長国連邦
      • その他中東とアフリカ
  • 中南米
    • 中南米
      • ブラジル
      • アルゼンチン
      • その他中南米

第13章 業界情勢

  • オルガノイド市場における成長戦略
  • 有機的成長戦略
    • 概要
  • 無機的成長戦略
    • 概要

第14章 企業プロファイル

  • STEMCELL Technologies Inc.
  • Molecular Devices, LLC.
  • Hubrecht Organoid Technology.
  • Definigen.
  • Organoid Therapeutics.
  • Thermo Fisher Scientific Inc.
  • Corning Inc.
  • Merck KGaA.
  • InSphero.
  • ACRO Biosystems.
  • Bio-Techne Corp.
  • SUN bioscience SA.
  • ORGANOID SCIENCES Co., Ltd.
  • Crown Bioscience Inc.
  • Sartorius AG.
  • 3D Biotek LLC.
  • Prellis Biologics Inc.
  • 3Dnamics Inc.
  • Cellesce Ltd.

第15章 付録

図表

List Of Tables

  • Table 1. Organoids Market Segmentation
  • Table 2. Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 3. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 4. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Application
  • Table 5. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Source
  • Table 6. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Offering
  • Table 7. Global: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 8. Global: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 9. Organoids Market - Revenue and Forecast to 2031 (US$ Million) - by Method
  • Table 10. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 11. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 12. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 13. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 14. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 15. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 16. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 17. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 18. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 19. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 20. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 21. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 22. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 23. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 24. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 25. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 26. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 27. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 28. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 29. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 30. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 31. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 32. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 34. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 35. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 36. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 37. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 38. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 39. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 40. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 41. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 42. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 43. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 44. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 45. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 46. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 47. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 48. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 49. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 50. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 51. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 52. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 53. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 54. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 55. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 56. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 57. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 58. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 59. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 60. France: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 61. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 62. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 63. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 64. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 65. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 66. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 67. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 68. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 69. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 70. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 71. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 72. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 73. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 74. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 75. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 76. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 77. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 78. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 79. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 80. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 81. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 82. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 83. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 84. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 85. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 86. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 87. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 88. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 89. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 90. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 91. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 92. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 93. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 94. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 95. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 96. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 97. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 98. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 99. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 100. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 101. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 102. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 103. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 104. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 105. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 106. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 107. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 108. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 109. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 110. China: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 111. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 112. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 113. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 114. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 115. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 116. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 117. India: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 118. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 119. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 120. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 121. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 122. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 123. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 124. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 125. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 126. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 127. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 128. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 129. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 130. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 131. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 132. Singapore: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 133. Singapore: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 134. Singapore: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 135. Singapore: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 136. Singapore: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 137. Singapore: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 138. Singapore: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 139. Thailand: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 140. Thailand: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 141. Thailand: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 142. Thailand: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 143. Thailand: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 144. Thailand: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 145. Thailand: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 146. Malaysia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 147. Malaysia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 148. Malaysia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 149. Malaysia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 150. Malaysia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 151. Malaysia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 152. Malaysia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 153. Vietnam: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 154. Vietnam: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 155. Vietnam: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 156. Vietnam: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 157. Vietnam: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 158. Vietnam: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 159. Vietnam: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 160. Indonesia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 161. Indonesia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 162. Indonesia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 163. Indonesia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 164. Indonesia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 165. Indonesia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 166. Indonesia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 167. Philippines: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 168. Philippines: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 169. Philippines: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 170. Philippines: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 171. Philippines: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 172. Philippines: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 173. Philippines: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 174. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 175. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 176. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 177. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 178. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 179. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 180. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 181. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 182. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 183. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 184. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 185. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 186. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 187. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 188. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 189. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 190. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 191. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 192. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 193. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 194. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 195. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 196. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 197. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 198. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 199. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 200. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 201. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 202. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 203. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 204. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 205. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 206. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 207. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 208. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 209. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 210. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 211. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 212. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 213. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 214. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 215. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 216. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 217. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 218. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 219. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 220. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 221. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 222. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 223. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 224. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Country
  • Table 225. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 226. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 227. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 228. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 229. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 230. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 231. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 232. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 233. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 234. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 235. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 236. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 237. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 238. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 239. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 240. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 241. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Source
  • Table 242. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Offering
  • Table 243. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Instruments
  • Table 244. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Consumables
  • Table 245. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million) - by Method
  • Table 246. Recent Organic Growth Strategies in Organoids Market
  • Table 247. Recent Inorganic Growth Strategies in the Organoids Market

List Of Figures

  • Figure 1. Organoids Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Organoids Market Revenue (US$ Million), 2021-2031
  • Figure 5. Organoids Market Share (%) - by Type (2023 and 2031)
  • Figure 6. Intestine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Liver: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Stomach: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Pancreas: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Lung: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Brain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Kidney: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Organoids Market Share (%) - by Application (2023 and 2031)
  • Figure 15. Developmental Biology Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Regenerative Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Organoids Market Share (%) - by Source (2023 and 2031)
  • Figure 22. Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Organ-Specific Adult Stem Cell: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Organoids Market Share (%) - by Offering (2023 and 2031)
  • Figure 25. Instruments: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Consumables: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Services: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Organoids Market Share (%) - by Method (2023 and 2031)
  • Figure 29. Micropatterned Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 30. Ultralow Attachment Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Hanging Drop: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Microdroplet or Emulsion: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. Organoids Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 35. North America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. North America: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 37. North America: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 38. North America: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 39. North America: Organoids Market Breakdown, by Offering (2023 and 2031)
  • Figure 40. North America: Organoids Market Breakdown, by Instruments (2023 and 2031)
  • Figure 41. North America: Organoids Market Breakdown, by Consumables (2023 and 2031)
  • Figure 42. North America: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 43. North America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 44. United States: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Canada: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Mexico: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. Europe: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 49. Europe: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 50. Europe: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 51. Europe: Organoids Market Breakdown, by Offering (2023 and 2031)
  • Figure 52. Europe: Organoids Market Breakdown, by Instruments (2023 and 2031)
  • Figure 53. Europe: Organoids Market Breakdown, by Consumables (2023 and 2031)
  • Figure 54. Europe: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 55. Europe: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 56. Germany: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 57. France: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 58. United Kingdom: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 59. Italy: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 60. Spain: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 61. Rest of Europe: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 62. Asia Pacific: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 63. Asia Pacific: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 64. Asia Pacific: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 65. Asia Pacific: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 66. Asia Pacific: Organoids Market Breakdown, by Offering (2023 and 2031)
  • Figure 67. Asia Pacific: Organoids Market Breakdown, by Instruments (2023 and 2031)
  • Figure 68. Asia Pacific: Organoids Market Breakdown, by Consumables (2023 and 2031)
  • Figure 69. Asia Pacific: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 70. Asia Pacific: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 71. Japan: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 72. China: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 73. India: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 74. South Korea: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 75. Australia: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 76. Singapore: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 77. Thailand: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 78. Malaysia: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 79. Vietnam: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 80. Indonesia: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 81. Philippines: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 82. Rest of APAC: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 83. Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 84. Middle East and Africa: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 85. Middle East and Africa: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 86. Middle East and Africa: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 87. Middle East and Africa: Organoids Market Breakdown, by Offering (2023 and 2031)
  • Figure 88. Middle East and Africa: Organoids Market Breakdown, by Instruments (2023 and 2031)
  • Figure 89. Middle East and Africa: Organoids Market Breakdown, by Consumables (2023 and 2031)
  • Figure 90. Middle East and Africa: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 91. Middle East and Africa: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 92. Saudi Arabia: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 93. South Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 94. United Arab Emirates: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 95. Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 96. South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 97. South and Central America: Organoids Market Breakdown, by Type (2023 and 2031)
  • Figure 98. South and Central America: Organoids Market Breakdown, by Application (2023 and 2031)
  • Figure 99. South and Central America: Organoids Market Breakdown, by Source (2023 and 2031)
  • Figure 100. South and Central America: Organoids Market Breakdown, by Offering (2023 and 2031)
  • Figure 101. South and Central America: Organoids Market Breakdown, by Instruments (2023 and 2031)
  • Figure 102. South and Central America: Organoids Market Breakdown, by Consumables (2023 and 2031)
  • Figure 103. South and Central America: Organoids Market Breakdown, by Method (2023 and 2031)
  • Figure 104. South and Central America: Organoids Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 105. Brazil: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 106. Argentina: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 107. Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 108. Growth Strategies in Organoids Market
目次
Product Code: TIPRE00017616

According to our new research study on "Organoids Market Forecast to 2031 -Global Analysis - by Type, Application, Source, and Geography," the market is anticipated to grow from US$ 3.03 billion in 2023 and is projected to reach US$ 15.01 billion by 2031; it is expected to register a CAGR of 22.1% during 2023-2031. Factors contributing to the organoids market growth include the rising demand for novel drug screening services, and an upsurge in the popularity of customized medications. However, the dearth of skilled professionals and stringent safety regulations hamper the market growth.

Organoids are simple tissue-engineered cell-based in vitro models that recapitulate many aspects of the complex structure and function of the corresponding in vivo tissue. They can be dissected and interrogated for fundamental mechanistic studies on development, regeneration and repair in human tissues, and can also be used in diagnostics, disease modelling, drug discovery and personalized medicine.

North America dominates the organoids market. Market players in the US are focusing on organic growth strategies to strengthen their foothold. In February 2023, Molecular Devices, LLC. and HUB Organoids (HUB) announced a strategic collaboration to continue the development of next-generation 3D biology technologies that drive step-change reduction in preclinical to clinical drug attrition. Further, increasing research and development activities, rising demand for tissue engineering and organ transplantation, and a high rate of organoid adoption are driving the organoid services market in the country. Organoids have the potential to overcome several previous limitations associated with biomedical research studies, with a high focus on making mechanistic insights on human development available for researchers, producing accurate models of human disease, and generating patient-matched tissue sources for regenerative medicine. Asia Pacific is anticipated to record the highest CAGR during 2023-2031.

Increasing Key Developments to Provide Market Opportunities in Future

The progress of the healthcare sector has led to a rise in the demand for organoids across the world. This increased demand contributes to new product developments, acquisitions, partnerships, product launches, and approvals on a global level. Major market players are involved in activities to ensure the innovation and development of efficient services and products. A few of the recent key developments are listed below:

In June 2024, Molecular Devices, LLC. formally opened its purpose-built facility in Cardiff, UK. The multimillion-pound facility was designed to accommodate the exclusive bioprocess workflow and innovative bioreactor technology of the business, allowing for the large-scale, quality-controlled production of PDOs. Substantial amounts of repeatable PDOs that are 3D-ready are available as a custom service and are cryopreserved in a manner that is ready for analysis. Researchers can defrost, plate, and use these products as needed.

In May 2024, InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research.

In July 2023, Molecular Devices launched a custom organoid line expansion service with unique bioprocess technology for high-throughput applications.

In February 2023, Molecular Devices, LLC., and HUB Organoids (HUB) announced a strategic collaboration to contribute to the continued development of next-generation 3D biology technologies that enable step-change reduction in preclinical to clinical drug attrition.

In December 2022, Molecular Devices, LLC. acquired Cellesce Ltd. This acquisition focuses on producing large-scale PDOs for various purposes, including drug screening, through contract development and production services.

In August 2021, STEMCELL Technologies and Hubrecht Organoid Technology (HUB) signed an agreement. As a part of this agreement, STEMCELL's Contract Assay Services division began providing its tissue-derived organoids, such as lung, intestinal, and liver organoids, for pre-clinical toxicology screening and non-cancer drug development services to HUB. These services would facilitate the integration of organoids into preclinical testing programs by researchers and drug development organizations to aid in the faster and more economical launch of new therapies.

Such key developments, launches, and strategic collaborations among market players create ample opportunities for the organoid market growth..

Application -Based Insights

By application, the market is segmented into developmental biology, infectious disease pathology, regenerative medicine, drug toxicity & efficacy testing, drug discovery & personalized medicine, and others. The developmental biology disease segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023-2031.

Source -Based Insights

Based on source, the organoids market is divided into pluripotent stem cells and organ-specific adult stem cells. The pluripotent stem cells segment held a larger share of the market in 2023. The pluripotent stem cells segment is anticipated to register a higher CAGR during the forecast period.

Organoids Market: Competitive Landscape and Key Developments

STEMCELL Technologies Inc, Molecular Devices, LLC., InSphero, Definigen, Organoid Therapeutics, Thermo Fisher Scientific Inc, Corning Inc, Merck KGaA, HUB Organoids B.V. (Hubrecht Organoid Technology) are among the key companies operating in the organoids market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Global Burden of Disease Study are among the primary and secondary sources referred to while preparing the organoids market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance.
  • 1.2 Market Segmentation.

2. Executive Summary

  • 2.1 Key Insights.

3. Research Methodology

  • 3.1 Secondary Research.
  • 3.2 Primary Research.
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Organoids Market Landscape

  • 4.1 PEST Analysis.

5. Organoids Market - Key Market Dynamics

  • 5.1 Organoids Market - Key Market Dynamics.
  • 5.2 Market Drivers.
    • 5.2.1 Increasing Demand for Tumor Modeling and Biobanking.
    • 5.2.2 Surging Adoption of Personalized Drugs.
  • 5.3 Market Restraints.
    • 5.3.1 Dearth of Skilled Professionals.
  • 5.4 Market Opportunities.
    • 5.4.1 Focus on Drug Discovery Activities.
  • 5.5 Future Trends.
    • 5.5.1 Combination of Organoids and Organ-on-a-Chip.
  • 5.6 Impact of Drivers and Restraints:

6. Organoids Market - Global Market Analysis

  • 6.1 Organoids Market Revenue (US$ Million), 2021-2031.
  • 6.2 Organoids Market Forecast Analysis.

7. Organoids Market Analysis - by Type

  • 7.1 Intestine.
    • 7.1.1 Overview.
    • 7.1.2 Intestine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Liver
    • 7.2.1 Overview.
    • 7.2.2 Liver: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Stomach.
    • 7.3.1 Overview.
    • 7.3.2 Stomach: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Pancreas.
    • 7.4.1 Overview.
    • 7.4.2 Pancreas: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Lung.
    • 7.5.1 Overview.
    • 7.5.2 Lung: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Brain.
    • 7.6.1 Overview.
    • 7.6.2 Brain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Kidney.
    • 7.7.1 Overview.
    • 7.7.2 Kidney: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.8 Others.
    • 7.8.1 Overview.
    • 7.8.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

8. Organoids Market Analysis - by Application

  • 8.1 Developmental Biology Disease.
    • 8.1.1 Overview.
    • 8.1.2 Developmental Biology Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Pathology of Infectious Disease.
    • 8.2.1 Overview.
    • 8.2.2 Pathology of Infectious Disease: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Regenerative Medicine.
    • 8.3.1 Overview.
    • 8.3.2 Regenerative Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Drug Toxicity and Efficacy Testing.
    • 8.4.1 Overview
    • 8.4.2 Drug Toxicity and Efficacy Testing: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.5 Drug Discovery and Personalized Medicine.
    • 8.5.1 Overview.
    • 8.5.2 Drug Discovery and Personalized Medicine: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.6 Others.
    • 8.6.1 Overview.
    • 8.6.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

9. Organoids Market Analysis - by Source

  • 9.1 Pluripotent Stem Cells
    • 9.1.1 Overview.
    • 9.1.2 Pluripotent Stem Cells: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.2 Organ-Specific Adult Stem Cell 70
    • 9.2.1 Overview.
    • 9.2.2 Organ-Specific Adult Stem Cell: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

10. Organoids Market Analysis - by Offering

  • 10.1 Instruments.
    • 10.1.1 Overview.
    • 10.1.2 Instruments: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.2 Consumables.
    • 10.2.1 Overview.
    • 10.2.2 Consumables: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Services.
    • 10.3.1 Overview.
    • 10.3.2 Services: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

11. Organoids Market Analysis - by Method

  • 11.1 Micropatterned Plates.
    • 11.1.1 Overview.
    • 11.1.2 Micropatterned Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.2 Ultralow Attachment Plates.
    • 11.2.1 Overview.
    • 11.2.2 Ultralow Attachment Plates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Hanging Drop.
    • 11.3.1 Overview.
    • 11.3.2 Hanging Drop: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Microdroplet or Emulsion.
    • 11.4.1 Overview.
    • 11.4.2 Microdroplet or Emulsion: Organoids Market - Revenue and Forecast to 2031 (US$ Million) 79
  • 11.5 Others.
    • 11.5.1 Overview.
    • 11.5.2 Others: Organoids Market - Revenue and Forecast to 2031 (US$ Million)

12. Organoids Market - Geographical Analysis

  • 12.1 Overview.
  • 12.2 North America.
    • 12.2.1 North America Organoids Market Overview.
    • 12.2.2 North America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.2.3 North America: Organoids Market Breakdown, by Type.
      • 12.2.3.1 North America: Organoids Market - Revenue and Forecast Analysis - by Type.
    • 12.2.4 North America: Organoids Market Breakdown, by Application.
      • 12.2.4.1 North America: Organoids Market - Revenue and Forecast Analysis - by Application.
    • 12.2.5 North America: Organoids Market Breakdown, by Source.
      • 12.2.5.1 North America: Organoids Market - Revenue and Forecast Analysis - by Source.
    • 12.2.6 North America: Organoids Market Breakdown, by Offering.
      • 12.2.6.1 North America: Organoids Market - Revenue and Forecast Analysis - by Offering.
    • 12.2.7 North America: Organoids Market Breakdown, by Instruments.
      • 12.2.7.1 North America: Organoids Market - Revenue and Forecast Analysis - by Instruments.
    • 12.2.8 North America: Organoids Market Breakdown, by Consumables.
      • 12.2.8.1 North America: Organoids Market - Revenue and Forecast Analysis - by Consumables.
    • 12.2.9 North America: Organoids Market Breakdown, by Method.
      • 12.2.9.1 North America: Organoids Market - Revenue and Forecast Analysis - by Method.
    • 12.2.10 North America: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.2.10.1 North America: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.2.10.2 United States: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.2.10.2.1 United States: Organoids Market Breakdown, by Type.
        • 12.2.10.2.2 United States: Organoids Market Breakdown, by Application.
        • 12.2.10.2.3 United States: Organoids Market Breakdown, by Source.
        • 12.2.10.2.4 United States: Organoids Market Breakdown, by Offering.
        • 12.2.10.2.5 United States: Organoids Market Breakdown, by Instruments.
        • 12.2.10.2.6 United States: Organoids Market Breakdown, by Consumables.
        • 12.2.10.2.7 United States: Organoids Market Breakdown, by Method.
      • 12.2.10.3 Canada: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.2.10.3.1 Canada: Organoids Market Breakdown, by Type.
        • 12.2.10.3.2 Canada: Organoids Market Breakdown, by Application.
        • 12.2.10.3.3 Canada: Organoids Market Breakdown, by Source.
        • 12.2.10.3.4 Canada: Organoids Market Breakdown, by Offering.
        • 12.2.10.3.5 Canada: Organoids Market Breakdown, by Instruments.
        • 12.2.10.3.6 Canada: Organoids Market Breakdown, by Consumables.
        • 12.2.10.3.7 Canada: Organoids Market Breakdown, by Method.
      • 12.2.10.4 Mexico: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.2.10.4.1 Mexico: Organoids Market Breakdown, by Type.
        • 12.2.10.4.2 Mexico: Organoids Market Breakdown, by Application.
        • 12.2.10.4.3 Mexico: Organoids Market Breakdown, by Source.
        • 12.2.10.4.4 Mexico: Organoids Market Breakdown, by Offering.
        • 12.2.10.4.5 Mexico: Organoids Market Breakdown, by Instruments.
        • 12.2.10.4.6 Mexico: Organoids Market Breakdown, by Consumables.
        • 12.2.10.4.7 Mexico: Organoids Market Breakdown, by Method.
  • 12.3 Europe.
    • 12.3.1 Europe Organoids Market Overview.
    • 12.3.2 Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.3.3 Europe: Organoids Market Breakdown, by Type.
      • 12.3.3.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Type.
    • 12.3.4 Europe: Organoids Market Breakdown, by Application.
      • 12.3.4.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Application.
    • 12.3.5 Europe: Organoids Market Breakdown, by Source.
      • 12.3.5.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Source.
    • 12.3.6 Europe: Organoids Market Breakdown, by Offering.
      • 12.3.6.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Offering.
    • 12.3.7 Europe: Organoids Market Breakdown, by Instruments.
      • 12.3.7.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Instruments.
    • 12.3.8 Europe: Organoids Market Breakdown, by Consumables.
      • 12.3.8.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Consumables.
    • 12.3.9 Europe: Organoids Market Breakdown, by Method.
      • 12.3.9.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Method.
    • 12.3.10 Europe: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.3.10.1 Europe: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.3.10.2 Germany: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.10.2.1 Germany: Organoids Market Breakdown, by Type.
        • 12.3.10.2.2 Germany: Organoids Market Breakdown, by Application.
        • 12.3.10.2.3 Germany: Organoids Market Breakdown, by Source.
        • 12.3.10.2.4 Germany: Organoids Market Breakdown, by Offering.
        • 12.3.10.2.5 Germany: Organoids Market Breakdown, by Instruments.
        • 12.3.10.2.6 Germany: Organoids Market Breakdown, by Consumables.
        • 12.3.10.2.7 Germany: Organoids Market Breakdown, by Method.
      • 12.3.10.3 France: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.10.3.1 France: Organoids Market Breakdown, by Type.
        • 12.3.10.3.2 France: Organoids Market Breakdown, by Application.
        • 12.3.10.3.3 France: Organoids Market Breakdown, by Source.
        • 12.3.10.3.4 France: Organoids Market Breakdown, by Offering.
        • 12.3.10.3.5 France: Organoids Market Breakdown, by Instruments.
        • 12.3.10.3.6 France: Organoids Market Breakdown, by Consumables.
        • 12.3.10.3.7 France: Organoids Market Breakdown, by Method.
      • 12.3.10.4 United Kingdom: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.10.4.1 United Kingdom: Organoids Market Breakdown, by Type.
        • 12.3.10.4.2 United Kingdom: Organoids Market Breakdown, by Application.
        • 12.3.10.4.3 United Kingdom: Organoids Market Breakdown, by Source.
        • 12.3.10.4.4 United Kingdom: Organoids Market Breakdown, by Offering.
        • 12.3.10.4.5 United Kingdom: Organoids Market Breakdown, by Instruments.
        • 12.3.10.4.6 United Kingdom: Organoids Market Breakdown, by Consumables.
        • 12.3.10.4.7 United Kingdom: Organoids Market Breakdown, by Method.
      • 12.3.10.5 Italy: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.10.5.1 Italy: Organoids Market Breakdown, by Type.
        • 12.3.10.5.2 Italy: Organoids Market Breakdown, by Application.
        • 12.3.10.5.3 Italy: Organoids Market Breakdown, by Source.
        • 12.3.10.5.4 Italy: Organoids Market Breakdown, by Offering.
        • 12.3.10.5.5 Italy: Organoids Market Breakdown, by Instruments.
        • 12.3.10.5.6 Italy: Organoids Market Breakdown, by Consumables.
        • 12.3.10.5.7 Italy: Organoids Market Breakdown, by Method.
      • 12.3.10.6 Spain: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.10.6.1 Spain: Organoids Market Breakdown, by Type.
        • 12.3.10.6.2 Spain: Organoids Market Breakdown, by Application.
        • 12.3.10.6.3 Spain: Organoids Market Breakdown, by Source.
        • 12.3.10.6.4 Spain: Organoids Market Breakdown, by Offering.
        • 12.3.10.6.5 Spain: Organoids Market Breakdown, by Instruments.
        • 12.3.10.6.6 Spain: Organoids Market Breakdown, by Consumables.
        • 12.3.10.6.7 Spain: Organoids Market Breakdown, by Method.
      • 12.3.10.7 Rest of Europe: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.3.10.7.1 Rest of Europe: Organoids Market Breakdown, by Type.
        • 12.3.10.7.2 Rest of Europe: Organoids Market Breakdown, by Application.
        • 12.3.10.7.3 Rest of Europe: Organoids Market Breakdown, by Source.
        • 12.3.10.7.4 Rest of Europe: Organoids Market Breakdown, by Offering.
        • 12.3.10.7.5 Rest of Europe: Organoids Market Breakdown, by Instruments.
        • 12.3.10.7.6 Rest of Europe: Organoids Market Breakdown, by Consumables.
        • 12.3.10.7.7 Rest of Europe: Organoids Market Breakdown, by Method.
  • 12.4 Asia Pacific.
    • 12.4.1 Asia Pacific Organoids Market Overview.
    • 12.4.2 Asia Pacific: Organoids Market - Revenue and Forecast to 2031 (US$ Million) 13
    • 12.4.3 Asia Pacific: Organoids Market Breakdown, by Type.
      • 12.4.3.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Type.
    • 12.4.4 Asia Pacific: Organoids Market Breakdown, by Application.
      • 12.4.4.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Application.
    • 12.4.5 Asia Pacific: Organoids Market Breakdown, by Source.
      • 12.4.5.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Source.
    • 12.4.6 Asia Pacific: Organoids Market Breakdown, by Offering.
      • 12.4.6.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Offering.
    • 12.4.7 Asia Pacific: Organoids Market Breakdown, by Instruments.
      • 12.4.7.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Instruments.
    • 12.4.8 Asia Pacific: Organoids Market Breakdown, by Consumables.
      • 12.4.8.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Consumables.
    • 12.4.9 Asia Pacific: Organoids Market Breakdown, by Method.
      • 12.4.9.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Method.
    • 12.4.10 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.4.10.1 Asia Pacific: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.4.10.2 Japan: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.2.1 Japan: Organoids Market Breakdown, by Type.
        • 12.4.10.2.2 Japan: Organoids Market Breakdown, by Application.
        • 12.4.10.2.3 Japan: Organoids Market Breakdown, by Source.
        • 12.4.10.2.4 Japan: Organoids Market Breakdown, by Offering
        • 12.4.10.2.5 Japan: Organoids Market Breakdown, by Instruments.
        • 12.4.10.2.6 Japan: Organoids Market Breakdown, by Consumables.
        • 12.4.10.2.7 Japan: Organoids Market Breakdown, by Method.
      • 12.4.10.3 China: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.3.1 China: Organoids Market Breakdown, by Type.
        • 12.4.10.3.2 China: Organoids Market Breakdown, by Application.
        • 12.4.10.3.3 China: Organoids Market Breakdown, by Source.
        • 12.4.10.3.4 China: Organoids Market Breakdown, by Offering.
        • 12.4.10.3.5 China: Organoids Market Breakdown, by Instruments.
        • 12.4.10.3.6 China: Organoids Market Breakdown, by Consumables.
        • 12.4.10.3.7 China: Organoids Market Breakdown, by Method.
      • 12.4.10.4 India: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.4.1 India: Organoids Market Breakdown, by Type.
        • 12.4.10.4.2 India: Organoids Market Breakdown, by Application
        • 12.4.10.4.3 India: Organoids Market Breakdown, by Source.
        • 12.4.10.4.4 India: Organoids Market Breakdown, by Offering
        • 12.4.10.4.5 India: Organoids Market Breakdown, by Instruments.
        • 12.4.10.4.6 India: Organoids Market Breakdown, by Consumables.
        • 12.4.10.4.7 India: Organoids Market Breakdown, by Method.
      • 12.4.10.5 South Korea: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.5.1 South Korea: Organoids Market Breakdown, by Type.
        • 12.4.10.5.2 South Korea: Organoids Market Breakdown, by Application.
        • 12.4.10.5.3 South Korea: Organoids Market Breakdown, by Source.
        • 12.4.10.5.4 South Korea: Organoids Market Breakdown, by Offering.
        • 12.4.10.5.5 South Korea: Organoids Market Breakdown, by Instruments.
        • 12.4.10.5.6 South Korea: Organoids Market Breakdown, by Consumables.
        • 12.4.10.5.7 South Korea: Organoids Market Breakdown, by Method.
      • 12.4.10.6 Australia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.6.1 Australia: Organoids Market Breakdown, by Type.
        • 12.4.10.6.2 Australia: Organoids Market Breakdown, by Application.
        • 12.4.10.6.3 Australia: Organoids Market Breakdown, by Source.
        • 12.4.10.6.4 Australia: Organoids Market Breakdown, by Offering.
        • 12.4.10.6.5 Australia: Organoids Market Breakdown, by Instruments.
        • 12.4.10.6.6 Australia: Organoids Market Breakdown, by Consumables.
        • 12.4.10.6.7 Australia: Organoids Market Breakdown, by Method.
      • 12.4.10.7 Singapore: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.7.1 Singapore: Organoids Market Breakdown, by Type.
        • 12.4.10.7.2 Singapore: Organoids Market Breakdown, by Application.
        • 12.4.10.7.3 Singapore: Organoids Market Breakdown, by Source.
        • 12.4.10.7.4 Singapore: Organoids Market Breakdown, by Offering.
        • 12.4.10.7.5 Singapore: Organoids Market Breakdown, by Instruments.
        • 12.4.10.7.6 Singapore: Organoids Market Breakdown, by Consumables.
        • 12.4.10.7.7 Singapore: Organoids Market Breakdown, by Method.
      • 12.4.10.8 Thailand: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.8.1 Thailand: Organoids Market Breakdown, by Type.
        • 12.4.10.8.2 Thailand: Organoids Market Breakdown, by Application.
        • 12.4.10.8.3 Thailand: Organoids Market Breakdown, by Source.
        • 12.4.10.8.4 Thailand: Organoids Market Breakdown, by Offering.
        • 12.4.10.8.5 Thailand: Organoids Market Breakdown, by Instruments.
        • 12.4.10.8.6 Thailand: Organoids Market Breakdown, by Consumables.
        • 12.4.10.8.7 Thailand: Organoids Market Breakdown, by Method.
      • 12.4.10.9 Malaysia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.9.1 Malaysia: Organoids Market Breakdown, by Type.
        • 12.4.10.9.2 Malaysia: Organoids Market Breakdown, by Application.
        • 12.4.10.9.3 Malaysia: Organoids Market Breakdown, by Source.
        • 12.4.10.9.4 Malaysia: Organoids Market Breakdown, by Offering.
        • 12.4.10.9.5 Malaysia: Organoids Market Breakdown, by Instruments.
        • 12.4.10.9.6 Malaysia: Organoids Market Breakdown, by Consumables.
        • 12.4.10.9.7 Malaysia: Organoids Market Breakdown, by Method.
      • 12.4.10.10 Vietnam: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.10.1 Vietnam: Organoids Market Breakdown, by Type.
        • 12.4.10.10.2 Vietnam: Organoids Market Breakdown, by Application.
        • 12.4.10.10.3 Vietnam: Organoids Market Breakdown, by Source.
        • 12.4.10.10.4 Vietnam: Organoids Market Breakdown, by Offering.
        • 12.4.10.10.5 Vietnam: Organoids Market Breakdown, by Instruments.
        • 12.4.10.10.6 Vietnam: Organoids Market Breakdown, by Consumables.
        • 12.4.10.10.7 Vietnam: Organoids Market Breakdown, by Method.
      • 12.4.10.11 Indonesia: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.11.1 Indonesia: Organoids Market Breakdown, by Type.
        • 12.4.10.11.2 Indonesia: Organoids Market Breakdown, by Application.
        • 12.4.10.11.3 Indonesia: Organoids Market Breakdown, by Source.
        • 12.4.10.11.4 Indonesia: Organoids Market Breakdown, by Offering.
        • 12.4.10.11.5 Indonesia: Organoids Market Breakdown, by Instruments.
        • 12.4.10.11.6 Indonesia: Organoids Market Breakdown, by Consumables.
        • 12.4.10.11.7 Indonesia: Organoids Market Breakdown, by Method.
      • 12.4.10.12 Philippines: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.12.1 Philippines: Organoids Market Breakdown, by Type.
        • 12.4.10.12.2 Philippines: Organoids Market Breakdown, by Application.
        • 12.4.10.12.3 Philippines: Organoids Market Breakdown, by Source.
        • 12.4.10.12.4 Philippines: Organoids Market Breakdown, by Offering.
        • 12.4.10.12.5 Philippines: Organoids Market Breakdown, by Instruments.
        • 12.4.10.12.6 Philippines: Organoids Market Breakdown, by Consumables.
        • 12.4.10.12.7 Philippines: Organoids Market Breakdown, by Method.
      • 12.4.10.13 Rest of APAC: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.4.10.13.1 Rest of APAC: Organoids Market Breakdown, by Type.
        • 12.4.10.13.2 Rest of APAC: Organoids Market Breakdown, by Application.
        • 12.4.10.13.3 Rest of APAC: Organoids Market Breakdown, by Source.
        • 12.4.10.13.4 Rest of APAC: Organoids Market Breakdown, by Offering.
        • 12.4.10.13.5 Rest of APAC: Organoids Market Breakdown, by Instruments.
        • 12.4.10.13.6 Rest of APAC: Organoids Market Breakdown, by Consumables.
        • 12.4.10.13.7 Rest of APAC: Organoids Market Breakdown, by Method.
  • 12.5 Middle East and Africa.
    • 12.5.1 Middle East and Africa Organoids Market Overview.
    • 12.5.2 Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.5.3 Middle East and Africa: Organoids Market Breakdown, by Type.
      • 12.5.3.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Type.
    • 12.5.4 Middle East and Africa: Organoids Market Breakdown, by Application.
      • 12.5.4.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Application.
    • 12.5.5 Middle East and Africa: Organoids Market Breakdown, by Source.
      • 12.5.5.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Source.
    • 12.5.6 Middle East and Africa: Organoids Market Breakdown, by Offering.
      • 12.5.6.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Offering.
    • 12.5.7 Middle East and Africa: Organoids Market Breakdown, by Instruments.
      • 12.5.7.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Instruments.
    • 12.5.8 Middle East and Africa: Organoids Market Breakdown, by Consumables.
      • 12.5.8.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Consumables.
    • 12.5.9 Middle East and Africa: Organoids Market Breakdown, by Method.
      • 12.5.9.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Method.
    • 12.5.10 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.5.10.1 Middle East and Africa: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.5.10.2 Saudi Arabia: Organoids Market - Revenue and Forecast to 2031 (US$ Million
        • 12.5.10.2.1 Saudi Arabia: Organoids Market Breakdown, by Type.
        • 12.5.10.2.2 Saudi Arabia: Organoids Market Breakdown, by Application.
        • 12.5.10.2.3 Saudi Arabia: Organoids Market Breakdown, by Source.
        • 12.5.10.2.4 Saudi Arabia: Organoids Market Breakdown, by Offering.
        • 12.5.10.2.5 Saudi Arabia: Organoids Market Breakdown, by Instruments.
        • 12.5.10.2.6 Saudi Arabia: Organoids Market Breakdown, by Consumables.
        • 12.5.10.2.7 Saudi Arabia: Organoids Market Breakdown, by Method.
      • 12.5.10.3 South Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.5.10.3.1 South Africa: Organoids Market Breakdown, by Type.
        • 12.5.10.3.2 South Africa: Organoids Market Breakdown, by Application.
        • 12.5.10.3.3 South Africa: Organoids Market Breakdown, by Source.
        • 12.5.10.3.4 South Africa: Organoids Market Breakdown, by Offering.
        • 12.5.10.3.5 South Africa: Organoids Market Breakdown, by Instruments.
        • 12.5.10.3.6 South Africa: Organoids Market Breakdown, by Consumables.
        • 12.5.10.3.7 South Africa: Organoids Market Breakdown, by Method.
      • 12.5.10.4 United Arab Emirates: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.5.10.4.1 United Arab Emirates: Organoids Market Breakdown, by Type.
        • 12.5.10.4.2 United Arab Emirates: Organoids Market Breakdown, by Application.
        • 12.5.10.4.3 United Arab Emirates: Organoids Market Breakdown, by Source.
        • 12.5.10.4.4 United Arab Emirates: Organoids Market Breakdown, by Offering.
        • 12.5.10.4.5 United Arab Emirates: Organoids Market Breakdown, by Instruments.
        • 12.5.10.4.6 United Arab Emirates: Organoids Market Breakdown, by Consumables.
        • 12.5.10.4.7 United Arab Emirates: Organoids Market Breakdown, by Method.
      • 12.5.10.5 Rest of Middle East and Africa: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.5.10.5.1 Rest of Middle East and Africa: Organoids Market Breakdown, by Type.
        • 12.5.10.5.2 Rest of Middle East and Africa: Organoids Market Breakdown, by Application.
        • 12.5.10.5.3 Rest of Middle East and Africa: Organoids Market Breakdown, by Source.
        • 12.5.10.5.4 Rest of Middle East and Africa: Organoids Market Breakdown, by Offering.
        • 12.5.10.5.5 Rest of Middle East and Africa: Organoids Market Breakdown, by Instruments.
        • 12.5.10.5.6 Rest of Middle East and Africa: Organoids Market Breakdown, by Consumables.
        • 12.5.10.5.7 Rest of Middle East and Africa: Organoids Market Breakdown, by Method.
  • 12.6 South and Central America.
    • 12.6.1 South and Central America Organoids Market Overview.
    • 12.6.2 South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
    • 12.6.3 South and Central America: Organoids Market Breakdown, by Type.
      • 12.6.3.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Type.
    • 12.6.4 South and Central America: Organoids Market Breakdown, by Application.
      • 12.6.4.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Application.
    • 12.6.5 South and Central America: Organoids Market Breakdown, by Source.
      • 12.6.5.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Source.
    • 12.6.6 South and Central America: Organoids Market Breakdown, by Offering.
      • 12.6.6.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Offering.
    • 12.6.7 South and Central America: Organoids Market Breakdown, by Instruments.
      • 12.6.7.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Instruments.
    • 12.6.8 South and Central America: Organoids Market Breakdown, by Consumables.
      • 12.6.8.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Consumables.
    • 12.6.9 South and Central America: Organoids Market Breakdown, by Method.
      • 12.6.9.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Method.
    • 12.6.10 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.6.10.1 South and Central America: Organoids Market - Revenue and Forecast Analysis - by Country.
      • 12.6.10.2 Brazil: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.6.10.2.1 Brazil: Organoids Market Breakdown, by Type.
        • 12.6.10.2.2 Brazil: Organoids Market Breakdown, by Application.
        • 12.6.10.2.3 Brazil: Organoids Market Breakdown, by Source.
        • 12.6.10.2.4 Brazil: Organoids Market Breakdown, by Offering.
        • 12.6.10.2.5 Brazil: Organoids Market Breakdown, by Instruments.
        • 12.6.10.2.6 Brazil: Organoids Market Breakdown, by Consumables.
        • 12.6.10.2.7 Brazil: Organoids Market Breakdown, by Method.
      • 12.6.10.3 Argentina: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.6.10.3.1 Argentina: Organoids Market Breakdown, by Type.
        • 12.6.10.3.2 Argentina: Organoids Market Breakdown, by Application.
        • 12.6.10.3.3 Argentina: Organoids Market Breakdown, by Source.
        • 12.6.10.3.4 Argentina: Organoids Market Breakdown, by Offering.
        • 12.6.10.3.5 Argentina: Organoids Market Breakdown, by Instruments.
        • 12.6.10.3.6 Argentina: Organoids Market Breakdown, by Consumables.
        • 12.6.10.3.7 Argentina: Organoids Market Breakdown, by Method.
      • 12.6.10.4 Rest of South and Central America: Organoids Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.6.10.4.1 Rest of South and Central America: Organoids Market Breakdown, by Type.
        • 12.6.10.4.2 Rest of South and Central America: Organoids Market Breakdown, by Application.
        • 12.6.10.4.3 Rest of South and Central America: Organoids Market Breakdown, by Source.
        • 12.6.10.4.4 Rest of South and Central America: Organoids Market Breakdown, by Offering.
        • 12.6.10.4.5 Rest of South and Central America: Organoids Market Breakdown, by Instruments.
        • 12.6.10.4.6 Rest of South and Central America: Organoids Market Breakdown, by Consumables.
        • 12.6.10.4.7 Rest of South and Central America: Organoids Market Breakdown, by Method.

13. Industry Landscape

  • 13.1 Overview.
  • 13.2 Growth Strategies in Organoids Market
  • 13.3 Organic Growth Strategies.
    • 13.3.1 Overview.
  • 13.4 Inorganic Growth Strategies.
    • 13.4.1 Overview.

14. Company Profiles

  • 14.1 STEMCELL Technologies Inc.
    • 14.1.1 Key Facts.
    • 14.1.2 Business Description.
    • 14.1.3 Products and Services.
    • 14.1.4 Financial Overview.
    • 14.1.5 SWOT Analysis.
    • 14.1.6 Key Developments.
  • 14.2 Molecular Devices, LLC.
    • 14.2.1 Key Facts.
    • 14.2.2 Business Description.
    • 14.2.3 Products and Services.
    • 14.2.4 Financial Overview.
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments.
  • 14.3 Hubrecht Organoid Technology.
    • 14.3.1 Key Facts.
    • 14.3.2 Business Description.
    • 14.3.3 Products and Services.
    • 14.3.4 Financial Overview.
    • 14.3.5 SWOT Analysis.
    • 14.3.6 Key Developments.
  • 14.4 Definigen.
    • 14.4.1 Key Facts.
    • 14.4.2 Business Description.
    • 14.4.3 Products and Services.
    • 14.4.4 Financial Overview.
    • 14.4.5 SWOT Analysis.
    • 14.4.6 Key Developments.
  • 14.5 Organoid Therapeutics.
    • 14.5.1 Key Facts.
    • 14.5.2 Business Description.
    • 14.5.3 Products and Services.
    • 14.5.4 Financial Overview.
    • 14.5.5 SWOT Analysis.
    • 14.5.6 Key Developments.
  • 14.6 Thermo Fisher Scientific Inc.
    • 14.6.1 Key Facts.
    • 14.6.2 Business Description.
    • 14.6.3 Products and Services.
    • 14.6.4 Financial Overview.
    • 14.6.5 SWOT Analysis.
    • 14.6.6 Key Developments.
  • 14.7 Corning Inc.
    • 14.7.1 Key Facts.
    • 14.7.2 Business Description.
    • 14.7.3 Products and Services.
    • 14.7.4 Financial Overview.
    • 14.7.5 SWOT Analysis.
    • 14.7.6 Key Developments.
  • 14.8 Merck KGaA.
    • 14.8.1 Key Facts.
    • 14.8.2 Business Description.
    • 14.8.3 Products and Services.
    • 14.8.4 Financial Overview.
    • 14.8.5 SWOT Analysis.
    • 14.8.6 Key Developments.
  • 14.9 InSphero.
    • 14.9.1 Key Facts.
    • 14.9.2 Business Description.
    • 14.9.3 Products and Services.
    • 14.9.4 Financial Overview.
    • 14.9.5 SWOT Analysis.
    • 14.9.6 Key Developments.
  • 14.10 ACRO Biosystems.
    • 14.10.1 Key Facts.
    • 14.10.2 Business Description.
    • 14.10.3 Products and Services.
    • 14.10.4 Financial Overview.
    • 14.10.5 SWOT Analysis.
    • 14.10.6 Key Developments.
  • 14.11 Bio-Techne Corp.
    • 14.11.1 Key Facts.
    • 14.11.2 Business Description.
    • 14.11.3 Products and Services.
    • 14.11.4 Financial Overview.
    • 14.11.5 SWOT Analysis.
    • 14.11.6 Key Developments.
  • 14.12 SUN bioscience SA.
    • 14.12.1 Key Facts.
    • 14.12.2 Business Description.
    • 14.12.3 Products and Services.
    • 14.12.4 Financial Overview.
    • 14.12.5 SWOT Analysis.
    • 14.12.6 Key Developments.
  • 14.13 ORGANOID SCIENCES Co., Ltd.
    • 14.13.1 Key Facts.
    • 14.13.2 Business Description.
    • 14.13.3 Products and Services.
    • 14.13.4 Financial Overview.
    • 14.13.5 SWOT Analysis.
    • 14.13.6 Key Developments.
  • 14.14 Crown Bioscience Inc.
    • 14.14.1 Key Facts.
    • 14.14.2 Business Description.
    • 14.14.3 Products and Services.
    • 14.14.4 Financial Overview.
    • 14.14.5 SWOT Analysis.
    • 14.14.6 Key Developments.
  • 14.15 Sartorius AG.
    • 14.15.1 Key Facts.
    • 14.15.2 Business Description.
    • 14.15.3 Products and Services.
    • 14.15.4 Financial Overview.
    • 14.15.5 SWOT Analysis.
    • 14.15.6 Key Developments.
  • 14.16 3D Biotek LLC.
    • 14.16.1 Key Facts.
    • 14.16.2 Business Description.
    • 14.16.3 Products and Services.
    • 14.16.4 Financial Overview.
    • 14.16.5 SWOT Analysis.
    • 14.16.6 Key Developments.
  • 14.17 Prellis Biologics Inc.
    • 14.17.1 Key Facts.
    • 14.17.2 Business Description.
    • 14.17.3 Products and Services.
    • 14.17.4 Financial Overview.
    • 14.17.5 SWOT Analysis.
    • 14.17.6 Key Developments.
  • 14.18 3Dnamics Inc.
    • 14.18.1 Key Facts.
    • 14.18.2 Business Description.
    • 14.18.3 Products and Services.
    • 14.18.4 Financial Overview.
    • 14.18.5 SWOT Analysis.
    • 14.18.6 Key Developments.
  • 14.19 Cellesce Ltd.
    • 14.19.1 Key Facts.
    • 14.19.2 Business Description.
    • 14.19.3 Products and Services.
    • 14.19.4 Financial Overview.
    • 14.19.5 SWOT Analysis.
    • 14.19.6 Key Developments.

15. Appendix

  • 15.1 About The Insight Partners.